Premenstrual disorders

@article{Yonkers2018PremenstrualD,
  title={Premenstrual disorders},
  author={K. Yonkers and M. Simoni},
  journal={American Journal of Obstetrics and Gynecology},
  year={2018},
  volume={218},
  pages={68–74}
}
&NA; Premenstrual disorders include premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual worsening of another medical condition. While the underlying causes of these conditions continue to be explored, an aberrant response to hormonal fluctuations that occurs with the natural menstrual cycle and serotonin deficits have both been implicated. A careful medical history and daily symptom monitoring across 2 menstrual cycles is important in establishing a diagnosis. Many… Expand
Investigation of auditory potentials and cognitive impairment in premenstrual syndrome
TLDR
In this study, it is aimed to reveal if cognitive functions are affected or not in PMS and if the subjects are affected, to explain this situation by an objective diagnostic test. Expand
Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study
TLDR
Women with GAD were more likely to have Premenstrual dysphoric disorder and their anxiety, depression, and irritability should be intervened not only in the luteal phase, but also in the follicular phase. Expand
Premenstrual symptoms as a marker of ovarian hormone sensitivity in eating disorders.
TLDR
Women who experience physical and psychological PMS may be at risk for eating disorder symptoms; PMS could be a marker of ovarian hormone sensitivity in women atrisk for an eating disorder. Expand
Associations between Plasma 25-Hydroxyvitamin D, Hormonal Contraceptives, and Premenstrual Symptoms
TLDR
Findings suggest HC use may be an effective targeted treatment and vitamin D status may be a risk factor for individual premenstrual symptoms. Expand
Reproductive Affective Disorders: a Review of the Genetic Evidence for Premenstrual Dysphoric Disorder and Postpartum Depression
TLDR
Evidence is stronger for the genetic basis for PPD, with positive associations found in family studies and in several genes associated with major depression as well as genes involved in estrogen signaling but only when PPD onset is shortly after delivery. Expand
Pubertal development and risk of premenstrual disorders in young adulthood
TLDR
The findings suggest that pubertal timing, particularly timing of menarche, is inversely associated with the risk of developing premenstrual symptoms in young adulthood, and that women with later menarches have significantly lower risk of PMDs. Expand
Prevalence of premenstrual syndrome and its psychological effects among university students who participate and do not participate in resistance training
  • Eliane Aragão da Silva, D. Pires
  • Medicine
  • 2021
TLDR
It is concluded that women who participate in resistance training have reduced indicators of some psychological symptoms of PMS. Expand
Physical and Psychological Symptoms Associated With Premenstrual Syndrome and Their Impact on the Daily Routine of Women in a Low Socioeconomic Status Locality
TLDR
A generally negative attitude towards menstruation was reflected, which significantly affected the routine lives of women in the authors' setting, and dysmenorrhea, fatigue, irritability, and anxiety were the most common symptoms of PMS experienced by women. Expand
Reproductive Depression and the Response to Hormone Therapy
TLDR
The range and aetiology of depression in women is different than in men and cannot be understood without knowledge of the effect that oestrogen, progesterone and androgens have upon mood. Expand
Estrogen levels, emotion regulation, and emotional symptoms of women with premenstrual dysphoric disorder: The moderating effect of estrogen receptor 1α polymorphism
TLDR
The association between estrogen and anxiety in PMDD is demonstrated, supporting the claim that women with PMDD differ in their responses to normal estrogen levels, and among the G carriers of ESR &agr;‐Xbal polymorphism. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 76 REFERENCES
Premenstrual Dysphoric Disorder: Epidemiology and Treatment
TLDR
Recent literature on potential contributors to premenstrual dysphoric disorder’s pathophysiology, including neurosteroids and stress, are presented, and potential treatment targets are explored. Expand
Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
TLDR
The effectiveness and safety of non-contraceptive oestrogen-containing preparations in the management of PMS in women of reproductive age with PMS diagnosed by at least two prospective cycles without current psychiatric disorder was determined. Expand
Epidemiology of premenstrual symptoms and disorders
TLDR
Premenstrual symptoms are a frequent source of concern to women during their reproductive lives and moderate to severe symptoms impact on their quality of lives. Expand
Effects of metergoline on symptoms in women with premenstrual dysphoric disorder.
TLDR
These data support the role of altered serotonergic transmission in the efficacy of SSRI treatment for premenstrual dysphoric disorder. Expand
Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.
TLDR
It is demonstrated that the change in estradiol/progesterone levels from low to high, and not the steady-state level, was associated with onset of PMDD symptoms and therapeutic efforts to modulate thechange in steroid levels proximate to ovulation merit further study. Expand
Selective serotonin reuptake inhibitors for premenstrual syndrome.
TLDR
SSRIs were effective for symptom relief whether taken only in the luteal phase or continuously, with no clear evidence of a difference in effectiveness between these modes of administration. Expand
Premenstrual syndromes: overview from a methodologic perspective.
TLDR
The authors offer recommendations to both investigators and clinicians for more careful observation and documentation of the relationship between mood disorders and the menstrual cycle. Expand
Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China.
TLDR
The prevalence of PMS/PMDD and the frequency and severity of the symptoms have their own characteristics in Chinese women. Expand
Progesterone for premenstrual syndrome.
TLDR
The trials did not show that progesterone is an effective treatment for PMS nor that it is not, and neither trial distinguished a subgroup of women who benefited, nor examined claimed success with high doses. Expand
Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets.
TLDR
The combined cohort suggest that 4 symptoms are linked with impairment from PMDD symptoms, which is informative for DSM-5 in that the most symptomatic period typically includes the few days before through the first 3 days of menses rather than only the premenstrual phase. Expand
...
1
2
3
4
5
...